[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"biomarker:tnfrsf13c-wt-allele":3},{"name":4,"total":5,"recruiting":5,"trials":6},"TNFRSF13C wt Allele",1,[7],{"nct_id":8,"title":9,"phases":10,"status":12,"updated_at":13,"content_modified":14},"NCT06191887","B-Cell Activating Factor Receptor (BAFFR)-Based Chimeric Antigen Receptor T-Cells With Fludarabine and Cyclophosphamide Lymphodepletion for the Treatment of Relapsed or Refractory B-cell Hematologic Malignancies",[11],"Phase 1","RECRUITING","2026-08-26T02:18:48.678868Z","2026-05-05T02:43:28.173828Z"]